B Reddy

B Reddy

Auto-generated profile, based on publicly available information

B Reddy

Chitkara Centre for Research and Development, Chitkara University, Himachal Pradesh-174103 India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Seminars in Medical Writing and Education
Verified
Journal Article
Open access
PDF file
PSPrerak Sudan
Prerak Sudan
TWTanveer A. Wani
Tanveer A. Wani
PVPooja Varma
Pooja Varma
SPShashikant Patil
Shashikant Patil
ASAmbika Sahoo
Ambika Sahoo
BRB Reddy
B Reddy
This article discusses the processes and applications of biosynthesized quantum dots (QD) in biotechnology. QD are nanoscale semiconductor particles with unique optical and electronic properties, making them attractive for various applications. The biosynthesis of QD involves the use of biological entities to produce nanoparticles (NPs), allowing for precise control of size and shape. QD is highly advantageous over organic fluorophores because of their distinct optical and chemical properties, and they can be utilized as fluorescent indicators for various biological applications. This article also discusses the advantages of biosynthesis over traditional chemical synthesis methods, including the use of less toxic materials and a lower environmental impact. In the future, the potential of QD is closely tied to the advancement of new generations of particles that possess precise and uniform dimensions, as well as unique optical properties.

29 August 2025 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
APAdya Kinkar Panda
Adya Kinkar Panda
RBReddy B
Reddy B
AKAmit Kumar
Amit Kumar
KSKamineni Sairam
Kamineni Sairam
AGAnand Gudur
Anand Gudur
SMSangeetha M
Sangeetha M
Many treatments for cancer have limited effectiveness and serious side effects, but it is still one of the main reasons of illness and death around the world. Because DNA abnormalities and the misregulation of signaling pathways make cancer so complicated, we need to find new therapy targets so that we can make medicines that work better and are more tailored to each person. Important cancer-causing pathways, including the PI3K/AKT/mTOR, MAPK/ERK, Wnt/β-catenin, and JAK/STAT pathways, help cells grow, survive, form new blood vessels, and hide from the immune system. Understanding the molecular processes that control these pathways has made it possible to create tailored treatments that stop the abnormal signals that cause cancer to spread. This study looks at the current state of therapeutic targets and how key tumor pathways are used to treat cancer. New tailored therapies, like small chemicals, monoclonal antibodies, and immune checkpoint inhibitors, have shown promise in both clinical studies and everyday use. Resistance to these medicines, on the other hand, is still a big problem. Resistance mechanisms, like changes in the target gene, the start of alternative pathways, or immune escape, make treatment results more difficult and need more research. Combining genetic analysis and precision medicine makes it possible to find changes that are unique to cancer. This makes it easier to create personalized therapies that are better at beating treatment resistance. Using focused medicines along with standard treatments like radiation and chemotherapy is a new way to improve treatment effectiveness and reduce resistance.

6 August 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
VSVundela Swathi
Vundela Swathi
ADAniruddh Dash
Aniruddh Dash
CMChandana Majee
Chandana Majee
PSPrerak Sudan
Prerak Sudan
VSV.A Satre
V.A Satre
BRB Reddy
B Reddy
Severe disability might result from a chronic carpometacarpal (CMC) dislocation. Displacement of the pollex's CMC joint is a rather rare damage. The anterior oblique ligament (AOL) has historically been the focus of surgical surgery, but more lately, the dorsoradial ligament (DRL) has drawn greater attention. Both ligaments must be considered to get the optimum functional outcomes during CMC joint rehabilitation. The purpose of this research was to examine the treatment of a case with severe dislocation of the thumb CMC joints. Case report: Following a motorbike accident, a 34-year-old man came with acute discomfort in his left hand. The diagnosis is that the man had many second to fifth CMC joint fracture-dislocations. Under general anesthesia, man had successful closure reduction and numerous Kirshner wire (K-wire) fixation. Excellent clinical outcomes tore verified after a one-year follow-up. Nonetheless, it includes the proportion of patient average mean value, loss of reduction, DASH score, Numeric rating scale (NSR), grip strength. For all dislocations of the CMC joint, it is advisable to use the closed reduction. To get a stable fixation and fantastic outcomes, K-wire fixation maybe incorporated. Acute or subacute thumb CMC joint displacement may be cured by fixing the dorsoradial muscle and anchoring it. Rarely do CMC fracture-dislocations include several bones. For a precise diagnosis, simple radiography and clinical exams are required. It is common practice to treat fractures and dislocations. Successful in the instance was a straightforward closed reduction with K-wires repair.

31 December 2024 in Seminars in Medical Writing and Education
Verified
Journal Article
Open access
PDF file
NRNeha Rana
Neha Rana
MMManashree Mane
Manashree Mane
BVBodireddy Vamalatha
Bodireddy Vamalatha
BRB Reddy
B Reddy
NKNaresh Kaushik
Naresh Kaushik
APAdya Kinkar Panda
Adya Kinkar Panda
Recently, a lot of progress has been made in using radiation therapy to treat cancer. The two most common methods are 3D Conformal Radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy (IMRT). Both ways try to give tumors the exact amount of radiation they need while causing as little damage as possible to good cells around them. In this study, the clinical results and treatment effectiveness of 3D-CRT and IMRT are compared in cancer patients with different types of radiation therapy. A historical cohort study included 120 patients from different hospitals. They were split into two groups, with one group getting 3D-CRT and the other IMRT. The main goals of the study were to compare the two groups in terms of tumor control rates, side effects from treatment, and overall survival (OS). The effectiveness of the treatment was also judged by looking at the total time needed for planning and carrying out the treatment, as well as the radiation doses given to both the tumor and healthy cells. Overall, our results showed that IMRT had better tumor control rates than 3D-CRT, with more cases of local control and fewer cases of cancer coming back at treatment sites. When compared to 3D-CRT, the IMRT group had a significantly lower rate of acute radiation-induced effects, such as skin discomfort and stomach problems. Because it can send out very directed radiation beams, IMRT was also linked to less damage to good organs around the tumor, like the spinal cord and lungs. IMRT, on the other hand, needs more complicated treatment planning and takes longer to give than 3D-CRT, which can make prices and resource use go up. Even so, IMRT's higher level of accuracy made it a clear winner when it came to controlling tumors and improving patients' quality of life.